Battle for cancer drug lost
A retired fireman has suffered a setback in his battle to win funding for a cancer drug.Liver cancer patient Barry Humphrey has lost an appeal for a £5,000 trial for a drug aimed at buying him more time.
A retired fireman has suffered a setback in his battle to win funding for a cancer drug.
Liver cancer patient Barry Humphrey has lost an appeal for a £5,000 trial for a drug aimed at buying him more time.
His upset wife Hazel says health bosses have “sentenced him to an early death” .
Mr Humphrey, from North Walsham, said “my life is not worth £5,000” but is vowing to keep fighting.
You may also want to watch:
Back in May, the News told how, after 25 years' service saving lives as a fireman in London, he had developed a rare cancer, triggered by hepatitis caught from a casualty during a rescue.
But officials at NHS Norfolk have decided not to fund treatment recommended by his consultant, saying Mr Humphrey's case fails to meet national cost-effectiveness guidelines.
- 1 Trains cancelled due to flooding - and more heavy rain expected
- 2 Classic cars raise hundreds for charity at Mundesley Motor Show
- 3 £2m bid for 62 new independent living apartments for over 55s
- 4 Stunning sunset artwork being raffled for new cancer centre
- 5 Man taken to hospital after cardiac arrest at beach
- 6 Former hunting lodge for sale for £1.695m with huge lake
- 7 Objectors gather to protest against 60ft 5G phone mast plans
- 8 'Lost a couple of staff members a day' - how the 'pingdemic' is hitting Norfolk
- 9 Market organiser vows big return after weather fears spark cancellation
- 10 Goats on a slope return to seaside town for summer grazing
NHS Norfolk medical director Bryan Heap said treatment funding decisions were taken on clinical rather than social circumstances, so Mr Humphrey's past as an exemplary citizen unfortunately could not be taken into consideration.
The cost of Sorafenib, along with administration, extra scans and follow-up was £150,000 a year, and trials indicated an increase in life expectancy of 12 weeks.